Price T Rowe Associates Inc Pliant Therapeutics, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,959,088 shares of PLRX stock, worth $51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,959,088
Previous 3,785,916
4.57%
Holding current value
$51 Million
Previous $68.6 Million
13.96%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding PLRX
# of Institutions
149Shares Held
63.9MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$74 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$59.9 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$45.5 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$44.8 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY3.47MShares$44.7 Million0.45% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $627M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...